This guidance from the World Health Organization (WHO) updates and adapts the previous work of WHO on research capacity for well-designed and well-implemented clinical trials as framed in resolution WHA75.8 (2022). It aims to enhance clinical research efficiency, minimise research waste and provide guidance on sustained clinical trials that are always functional and active for endemic conditions and can pivot in time of emergency or pandemics.
Registered address:
Patient Safety Learning, China Works SB203, 100 Black Prince Road Vauxhall, London, SE1 7SJ
Important Information
We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.
Recommended Comments
Create an account or sign in to comment